Valeant

A Q&A with the lawyer who alleges Valeant, the maker of Cold-fX, misled consumers about the short-term effectiveness of the cold and flu remedy

Here’s a stock tip Valeant investors should have heeded: If a company that’s not a bank becomes the largest in Canada, run!

Canada’s stock market has suffered through a lost decade of returns. Why the bad times for Canadian investors could continue.

In a market where so many have a vested interest in pumping up stock prices, short sellers serve as a necessary, if unwelcome, reality check

Canadians have found something else to be emotionally and financially invested in: real estate

The biotech giant Valeant is now at the top of the heap in Canada. Will it succumb to the curse of being the biggest company in the land?